Home › Harvard Case Study Analysis Solutions › ImmuLogic Pharmaceutical Corp. (B1): Malcolm Gefter

ImmuLogic Pharmaceutical Corp. (B1): Malcolm Gefter

Posted on Posted in Harvard Case Study Analysis Solutions

Subjects Covered
Entrepreneurial finance
Entrepreneurial management
Financial strategy
Stock offerings
Valuation

by
Josh Lerner

Source: Harvard Business School

2 pages.
Publication Date: Oct 22, 1992. Prod. #: 293067-PDF-ENG

ImmuLogic Pharmaceutical Corp. (B1): Malcolm Gefter Harvard Case Study Solution and HBR and HBS Case Analysis

Clients Who Bought This Case Solution Also Bought:

Zemanta
Share